Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
41.11
+0.20 (+0.49%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gsk Plc ADR
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
Activist Fund Elliott Management Wants GlaxoSmithKline Board Shakeup For 'Years Of Under Management'
July 01, 2021
Elliott Management has finally made its intentions around GlaxoSmithKline plc (NYSE: GSK) known and calls for changes to rescue GSK from what it called "years...
Via
Benzinga
GlaxoSmithKline's and Vir's Latest COVID Therapy Results: What Investors Should Know
July 01, 2021
The sample size was small, but the results were impressive.
Via
The Motley Fool
Exposures
COVID-19
EC Selects Antibody Therapies, Arthritis Drug As Preferred COVID-19 Meds: Reuters
June 29, 2021
The European Commission (EC) picked four antibody treatments and a repurposed Eli Lilly And Co's (NYSE: LLY) rheumatoid arthritis drug for an initial...
Via
Benzinga
Exposures
COVID-19
Saint Warren
June 28, 2021
Today the WTI oil price rose further up over 1%.
Via
Talk Markets
AstraZeneca COVID-19 Vaccine Shows Higher Immune Response With Longer Gap, Third Booster Dose
June 28, 2021
A sub-analysis from the Oxford-led COV001 and COV002 trials with AstraZeneca Plc (NASDAQ: AZN) COVID-19 vaccine induced strong immune responses following...
Via
Benzinga
Exposures
COVID-19
Wednesday Is A Normal Day
June 23, 2021
Meme stocks Gamestop and Torchlight Energy both did share sales to cash in on their share price rises.
Via
Talk Markets
A Look Into GlaxoSmithKline's Debt
June 23, 2021
Over the past three months, shares of GlaxoSmithKline (NYSE:GSK) increased by 9.84%. Before we understand the importance of debt, let us look at how much debt...
Via
Benzinga
Reconsidered Boom
June 22, 2021
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded.
Via
Talk Markets
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
June 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...
Via
Benzinga
Dual-Antibody Cocktail Shows Effectiveness In COVID-19 Animal Models: Reuters
June 22, 2021
In mice and hamster study, COVID-19 therapies comprising two types of antibodies were found to be effective against a wide range of COVID-19 variants, Reuters reported ...
Via
Benzinga
Exposures
COVID-19
GSK- Pfizer's ViiV To Develop 'Ultra-Long-Acting' HIV Drugs With $215M Halozyme Deal
June 22, 2021
GlaxoSmithKline plc (NYSE: GSK), Pfizer Inc (NYSE: PFE), and Shionogi Limited owned ViiV Healthcare has collaborated with Halozyme...
Via
Benzinga
The First Day Of Summer And Prime Day
June 21, 2021
The bull is back in business today.
Via
Talk Markets
GlaxoSmithKline CEO Struggling To Get Key Shareholders In Her Favor Amid Pressure From Hedge Fund Activist Elliott Management
June 21, 2021
GlaxoSmithKline Plc's (NYSE: GSK) CEO Emma Walmsley struggled to win over key shareholders after Elliott Management attracted converts for radical change at the company...
Via
Benzinga
GSK - Vir Biotech's Sotrovimab Reduces Hospitalization, Risk Of Death In Adult COVID-19 Patients
June 21, 2021
GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have announced final, confirmatory results from the Phase 3 COMET-ICE evaluating...
Via
Benzinga
Exposures
COVID-19
CureVac Stock Plummets After Covid Vaccine Fails In Interim Analysis
June 17, 2021
CureVac stock plummeted Thursday after its messenger RNA-based Covid vaccine failed in an interim analysis. The vaccine was 47% effective against Covid of any severity.
Via
Investor's Business Daily
Exposures
COVID-19
Tesla-Backed CureVac Plunges On Underwhelming COVID-19 Vaccine Efficacy Data
June 17, 2021
German vaccine developer, CureVac N.V. (NASDAQ: CVAC), may not be as fortunate as its domestic peer BioNTech SE (NASDAQ: BNTX), which along with its...
Via
Benzinga
Exposures
COVID-19
GSK: Can This Pharma Giant Sustain Its 5.2% Yield?
June 16, 2021
GlaxoSmithKline’s free cash flow has been up and down. Over the past three years, it has grown substantially, though this year, it is forecast to drop 18%.
Via
Talk Markets
Continued Uncertainty
June 15, 2021
Fear of another Fukushima yesterday late in the market day led to a rush out of energy-related shares, which included many without any nuclear risk at all.
Via
Talk Markets
Dreary Day
June 14, 2021
Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold.
Via
Talk Markets
IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings
June 14, 2021
This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Why iTeos Therapeutics Stock Soared Today
June 14, 2021
The biotech struck a potential $2 billion deal with a pharmaceutical giant.
Via
The Motley Fool
iTeos Therapeutics Stock Surges On $2.1B Development Pact For EOS-448 With GSK
June 14, 2021
iTeos Therapeutics (NASDAQ: ITOS) and GlaxoSmithKline plc (NYSE: GSK) have agreed to co-develop and co-commercialize EOS-448, an anti-TIGIT monoclonal...
Via
Benzinga
3 Dividend Stocks Wall Street Thinks Will Soar 20% or More
June 10, 2021
Attractive dividends plus strong growth? Yes, please.
Via
The Motley Fool
Wednesday News And Catch-Up
June 09, 2021
Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Juvenile Investing Mob
June 08, 2021
Tech stocks did well in Europe but not in the US. The data are unconvincing.
Via
Talk Markets
VBI Vaccines' Brain Cancer Immunotherapy Gets FDA Fast Track Review; Announces Updated Tumor Response, Overall Survival Data
June 08, 2021
The FDA has granted Fast Track Designation for VBI Vaccines Inc's (NASDAQ: VBIV) VBI-1901, its cancer vaccine immunotherapeutic candidate to treat...
Via
Benzinga
Exposures
Product Safety
Althera Expands Leadership Team in Anticipation of Roszet (rosuvastatin and ezetimibe) Tablets Launch
June 04, 2021
Dr. Patrick Aubonnet appointed as VP, Medical Affairs *** Ed Gutshall appointed as VP, head of Sales *** Dr. James Medley appointed as VP, Regulatory Affairs
Via
EIN Presswire
Fan Hit
June 03, 2021
The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares.
Via
Talk Markets
'Halftime Report' Traders Weigh In On GlaxoSmithKline, Snowflake And More
June 03, 2021
On CNBC's "Fast Money Halftime Report," Jenny Harrington said GlaxoSmithKline plc (NYSE: GSK) has performed terribly, but we could be at a beginning of value...
Via
Benzinga
Constellation Pharma Rockets On Word Of $1.7 Billion MorphoSys Takeover
June 02, 2021
MorphoSys announced its $1.7 billion plan to acquire cancer treatment biotech Constellation on Wednesday and CNST stock rocketed to a four-month high.
Via
Investor's Business Daily
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.